Login / Signup

Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.

Oluwadamilola M FayanjuLiza M QuintanaSamantha M ThomasSuniti N NimbkarTina J HiekenKandice K LudwigLisa K JacobsMegan E MillerKristalyn K GallagherJasmine WongHeather B NeumanJennifer TsengTaryn E HassingerTari A KingJames W JakubRex C BentleyStuart J Schnitt
Published in: Annals of surgical oncology (2021)
In this academic cohort of phyllodes tumors, one or more histopathologic features were frequently omitted from the pathology report. While all features were considered by the pathologist for grading, this limited reporting reflects a lack of reporting consensus. We recommend that standardized reporting in the form of a synoptic-style cancer protocol be implemented for phyllodes tumors, similar to other rare tumors.
Keyphrases
  • adverse drug
  • randomized controlled trial
  • squamous cell carcinoma
  • papillary thyroid
  • squamous cell